Search over 3,000 reports

    Celiac Disease - Market Insights, Epidemiology and Market Forecast - 2025

    Celiac Disease - Market Insights, Epidemiology and Market Forecast - 2025
    Date: Dec, 2017
    Type: Pharmaceutical Industry Report
    Pages: 70
    Geography: Global
    Delivery Timeline: 5 Business Days
    SKU: DIMI0012A
    DelveInsight's "Celiac Disease - Market Insights, Epidemiology and Market Forecast - 2025" report provides an overview of the disease and in depth research related to Celiac Disease for the 7MM (United States, Germany, France, Italy, Spain and UK) for the study period undertaken from 2015-2025. This report provides understanding of the patients affected, diagnosed patterns, treatment trends, unmet medical needs and current developments for Celiac Disease . It enables understanding of the historical and forecasted epidemiological data for the diagnosed prevalent cases of Celiac Disease for 7 major markets.

    The market outlook also provides understanding of country specific revenue and share by analyzing performance of the current therapies and thorough potential uptake of new products. Additionally, the Report highlights the frontrunners, the drivers and barriers for the Celiac Disease market, as well as treatment algorithm, current treatments & advancements are included.The chapters including marketed products highlights the advantages and disadvantages associated with therapies associated with Celiac Disease , providing an in-depth analysis of emerging therapies which will create an impact through their launch.

    According to DelveInsight, the forecasted patient population of Celiac Disease for the year 2025 will be XX, increasing at a CAGR of XX% from 2015 to 2025 and the Celiac Disease 7MM market size is estimated to be USD XX by 2025.The DelveInsight Report will help in enhanced understanding of the Celiac Disease market from inside out, with transparency into the calculated patient forecasting data and estimated market size.

    Key Coverage

    • Understanding historical and forecasted epidemiological data for Celiac Disease covering 7MM from 2015-2025.
    • Segment level epidemiology and market split for Celiac Disease .
    • The thorough assessment of competitors, market, current trends & treatments along with upcoming treatments for Celiac Disease .
    • The Report also covers the market size for 7MM (United States, EU 5 (Germany, Spain, Italy, France and United Kingdom) and Japan) from 2015-2025 and detailed historical and forecasted Celiac Disease market trends.
    • Thorough market distribution based on market share for Celiac Disease .

    Reasons to buy

    • The report will help in developing business strategies by understanding trends shaping and driving the Celiac Disease market.
    • To understand the future market competition in the Celiac Disease market and Insightful review of the key market drivers and barriers.
    • Organize sales and marketing efforts by identifying the best opportunities for Celiac Disease in US, Europe (Germany, Spain, Italy, France and United Kingdom) and Japan.
    • Identification of strong upcoming players in market will help in devising strategies that will help in getting ahead of competitors.

    1. Report Introduction
    2. Celiac Disease Market Overview at a Glance
    2.1. Total Market Share Distribution of Celiac Disease for 7 MM in 2016
    2.2. Total Market Share Distribution of Celiac Disease for 7 MM in 2025
    3. Celiac Disease
    3.1.1. Overview
    3.1.2. Symptoms
    3.1.3. Pathophysiology
    3.1.4. Staging
    3.1.5. Diagnosis
    3.1.6. Treatment
    4. Epidemiology and Patient Population
    4.1.1. United States
    4.1.1.1. Diagnosed Cases of Celiac Disease in United States
    4.1.2. Germany
    4.1.2.1. Diagnosed Cases of Celiac Disease in Germany
    4.1.3. France
    4.1.3.1. Diagnosed Cases of Celiac Disease in France
    4.1.4. Italy
    4.1.4.1. Diagnosed Cases of Celiac Disease in Italy
    4.1.5. Spain
    4.1.5.1. Diagnosed Cases of Celiac Disease in Spain
    4.1.6. United Kingdom
    4.1.6.1. Diagnosed Cases of Celiac Disease in United Kingdom
    5. Treatment Algorithm
    5.1.1. Treatment Guidelines/Practices
    6. Marketed Drugs for Celiac Disease
    6.1. Drug 1: Company A
    6.1.1. Drug Description
    6.1.2. Mechanism of Action
    6.1.3. Regulatory Milestones
    6.1.4. Advantages & Disadvantages
    6.1.5. Safety and Efficacy
    6.1.6. Product Profile
    6.1.7. Patent Status
    6.2. Drug 2: Company B
    6.2.1. Drug Description
    6.2.2. Mechanism of Action
    6.2.3. Regulatory Milestones
    6.2.4. Advantages & Disadvantages
    6.2.5. Safety and Efficacy
    6.2.6. Product Profile
    6.2.7. Patent Status
    7. Emerging Therapies
    7.1. Drug 3: Company C
    7.1.1. Description
    7.1.2. Regulatory Milestones
    7.1.3. Advantages & Disadvantages
    7.1.4. Product Profile
    7.1.5. Launch Date
    7.1.6. Clinical Development
    7.1.7. Clinical Pipeline Activity
    7.1.8. Ongoing Trials Information
    7.1.9. Clinical Trial by Phase
    7.2. Drug 4: Company B
    7.2.1. Description
    7.2.2. Regulatory Milestones
    7.2.3. Advantages & Disadvantages
    7.2.4. Product Profile
    7.2.5. Launch Date
    7.2.6. Clinical Development
    7.2.7. Clinical Pipeline Activity
    7.2.8. Ongoing Trials Information
    7.2.9. Clinical Trial by Phase
    8. Overview of Total Celiac Disease Market (2016 & 2025)
    9. Celiac Disease : Country-Wise Market Analysis
    9.1. United States
    9.1.1. Historical Market Size (2015-2016)
    9.1.2. Forecasted Market Size (2017-2025)
    9.2. Germany Market Size
    9.2.1. Historical Market Size (2015-2016)
    9.2.2. Forecasted Market Size (2017-2025)
    9.3. France Market Size
    9.3.1. Historical Market Size (2015-2016)
    9.3.2. Forecasted Market Size (2017-2025)
    9.4. United Kingdom Market Size
    9.4.1. Historical Market Size (2015-2016)
    9.4.2. Forecasted Market Size (2017-2025)
    9.5. Spain Market Size
    9.5.1. Historical Market Size (2015-2016)
    9.5.2. Forecasted Market Size (2017-2025)
    9.6. Italy Market Size
    9.6.1. Historical Market Size (2015-2016)
    9.6.2. Forecasted Market Size (2017-2025)
    9.7. Japan Market Size
    9.7.1. Historical Market Size (2015-2016)
    9.7.2. Forecasted Market Size (2017-2025)
    10. Market Drivers
    11. Market Restraints
    12. Appendix
    13. Report Methodology
    14. Consulting Services
    15. Disclaimer
    16. About DelveInsight
    Table 1: Diagnosed Cases Celiac Disease in United States (2015-2025)
    Table 2: Diagnosed Cases Celiac Disease in Germany (2015-2025)
    Table 3: Diagnosed Cases Celiac Disease in France (2015-2025)
    Table 4: Diagnosed Cases Celiac Disease in United Kingdom (2015-2025)
    Table 5: Diagnosed Cases Celiac Disease in Spain (2015-2025)
    Table 6: Diagnosed Cases Celiac Disease in Italy (2015-2025)
    Table 7: Diagnosed Cases Celiac Disease in Japan (2015-2025)
    Table 8: List of Marketed Drugs for Celiac Disease
    Table 9: List of Pipeline Phase III Drugs for Celiac Disease
    Table 10: Drug 1, Clinical Trials by Zone, 2017
    Table 11: Clinical Trials by Trial status, 2017
    Table 12: Drug 2, Clinical Trials by Zone, 2017
    Table 13: Clinical Trials by Trial status, 2017
    Table 14: Drug 3, Clinical Trials by Zone, 2017
    Table 15: Clinical Trials by Trial status, 2017
    Table 16: United States Market Size of Celiac Disease in USD, Million (2015-2025)
    Table 17: Germany Market Size of Celiac Disease in USD, Million (2015-2025)
    Table 18: France Market Size of Celiac Disease in USD, Million (2015-2025)
    Table 19: United Kingdom Market Size of Celiac Disease in USD, Million (2015-2025)
    Table 20: Spain Market Size of Celiac Disease in USD, Million (2015-2025)
    Table 21: Italy Market Size of Celiac Disease in USD, Million (2015-2025)
    Table 22: Japan Market Size of Celiac Disease in USD, Million (2015-2025)
    Figure 1: Diagnosed Cases Celiac Disease in United States (2015-2025)
    Figure 2: Diagnosed Cases Celiac Disease in Germany (2015-2025)
    Figure 3: Diagnosed Cases Celiac Disease in France (2015-2025)
    Figure 4: Diagnosed Cases Celiac Disease in United Kingdom (2015-2025)
    Figure 5: Diagnosed Cases Celiac Disease in Spain (2015-2025)
    Figure 6: Diagnosed Cases Celiac Disease in Italy (2015-2025)
    Figure 7: Diagnosed Cases Celiac Disease in Japan (2015-2025)
    Figure 8: List of Marketed Drugs for Celiac Disease
    Figure 9: List of Pipeline Phase III Drugs for Celiac Disease
    Figure 10: Drug 1, Clinical Trials by Zone (%), 2017
    Figure 11: Clinical Trials by Trial status, 2017
    Figure 12: Drug 2, Clinical Trials by Zone (%), 2017
    Figure 13: Clinical Trials by Trial status, 2017
    Figure 14: Drug 3, Clinical Trials by Zone (%), 2017
    Figure 15: Clinical Trials by Trial status, 2017
    Figure 16: United States Market Size of Celiac Disease in USD, Million (2015-2025)
    Figure 17: Germany Market Size of Celiac Disease in USD, Million (2015-2025)
    Figure 18: France Market Size of Celiac Disease in USD, Million (2015-2025)
    Figure 19: United Kingdom Market Size of Celiac Disease in USD, Million (2015-2025)
    Figure 20: Spain Market Size of Celiac Disease in USD, Million (2015-2025)
    Figure 21: Italy Market Size of Celiac Disease in USD, Million (2015-2025)
    Figure 22: Japan Market Size of Celiac Disease in USD, Million (2015-2025)
    Celiac Disease Market (7MM)

    Celiac Disease Market forecasting

    Celiac Disease Sales forecasting

    Celiac Disease Market segments

    Celiac Disease Epidemiology

    Celiac Disease Pipeline products and technologies

    Celiac Disease Competitive landscape

    Celiac Disease SWOT analysis

    Celiac Disease Market Driver's and barriers

    Celiac Disease Key Companies and Funding



    • Single User License
      (20% Off)
      $5,750.00
    • Site License
      (30% Off)
      $11,500.00
    • Global License
      (40% Off)
      $17,250.00

    Contact Us

    Phone
    +91-11-45689769, +91 9650213330

    Email
    info@delveinsight.com

    Address
    New Delhi-110075, India

    Latest Tweets

    • Copyright © 2017 Delveinsight.
    • Sitemap